Principia Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PRNB and buy or sell other stocks, ETFs, and their options commission-free!About PRNB
Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.
CEOMartin Babler
CEOMartin Babler
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2008
Founded2008
Employees—
Employees—
PRNB Key Statistics
Market cap3.32B
Market cap3.32B
Price-Earnings ratio-41.60
Price-Earnings ratio-41.60
Dividend yield—
Dividend yield—
Average volume793.58K
Average volume793.58K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$101.89
52 Week high$101.89
52 Week low$25.35
52 Week low$25.35
People also own
Based on the portfolios of people who own PRNB. This list is generated using Robinhood data, and it’s not a recommendation.